On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...